SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-2,987 Cr | ₹-2,714 Cr | ₹-1,998 Cr | ₹-1,316 Cr | ₹-1,515 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹-2,987 Cr |
| Mar2024 | ₹-2,714 Cr |
| Mar2023 | ₹-1,998 Cr |
| Mar2022 | ₹-1,316 Cr |
| Mar2021 | ₹-1,515 Cr |
How is Total Non-Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2,987 Cr | Negative | |
| Mar2024 | ₹-2,714 Cr | Negative | |
| Mar2023 | ₹-1,998 Cr | Negative | |
| Mar2022 | ₹-1,316 Cr | Negative | |
| Mar2021 | ₹-1,515 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,796.8 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,256.0 Cr | 3% | 0.8% | 7.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 2.8% |
1.8% |
13.4% |
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses